Stephens Consulting’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $78.4K | Buy |
1,122
+64
| +6% | +$4.47K | 0.02% | 150 |
|
|
2025
Q1 | $77.8K | Buy |
1,058
+402
| +61% | +$29.5K | 0.02% | 150 |
|
|
2024
Q4 | $43K | Hold |
656
| – | – | 0.01% | 199 |
|
|
2024
Q3 | $51.1K | Buy |
656
+1
| +0.2% | +$78 | 0.01% | 184 |
|
|
2024
Q2 | $51.1K | Sell |
655
-100
| -13% | -$7.8K | 0.01% | 177 |
|
|
2024
Q1 | $51.1K | Sell |
755
-127
| -14% | -$8.6K | 0.02% | 175 |
|
|
2023
Q4 | $59.4K | Hold |
882
| – | – | 0.02% | 161 |
|
|
2023
Q3 | $59.7K | Buy |
882
+1
| +0.1% | +$68 | 0.02% | 148 |
|
|
2023
Q2 | $63K | Hold |
881
| – | – | 0.03% | 144 |
|
|
2023
Q1 | $61.1K | Buy |
881
+2
| +0.2% | +$139 | 0.04% | 152 |
|
|
2022
Q4 | $59.6K | Sell |
879
-216
| -20% | -$14.6K | 0.04% | 157 |
|
|
2022
Q3 | $60K | Buy |
1,095
+130
| +13% | +$7.13K | 0.05% | 153 |
|
|
2022
Q2 | $63.7K | Sell |
965
-100
| -9% | -$6.6K | 0.05% | 148 |
|
|
2022
Q1 | $70.6K | Buy |
1,065
+48
| +5% | +$3.18K | 0.06% | 153 |
|
|
2021
Q4 | $59.3K | Buy |
+1,017
| New | +$59.3K | 0.05% | 179 |
|